The Brain Stimulation-Monitoring-Treatment or BSMT consortium has been organized and financed by the MAGNET Program of the Chief Scientist Officer (CSO) of the Israeli Ministry of Economy.
There are a large number of debilitating neuropsychiatric and neurological disorders . This represents a huge global disease burden/market (approximately, 700M cases/yr, $65B/yr…).
The consortium consists of 4 industrial companies (AlphaOmega LTD, Brainsway LTD, ElMindA LTD, and Insightec LTD) and 11 research groups from 5 different academic institutions.